Abstract
Cyclodextrins are cyclic oligomers of glucose. Their central cavities can hold small molecules, making them attractive for sensor and drug delivery applications. The most common cyclodextrins, CD6, CD7, and CD8, are made commercially via enzymatic processes. The smallest one previously chemically synthesized is CD5. Now Hidetoshi Yamada and coworkers at Kwansei Gakuin University report that they have chemically synthesized the smallest possible cyclodextrins, CD3 and CD4 (Science 2019, DOI: 10.1126/science.aaw3053). To achieve the synthesis, the researchers added a bridge between the O-3 and O-6 oxygen atoms of each glucose ring, which created a bicyclic structure. The bridge adjusts the conformation of the scaffold, shifting the glucose ring to a conformation that favors the α-1,4-glycosidic bond formation needed to make the desired strained cyclodextrins. Although the researchers were able to obtain CD3 and CD4, the synthesis worked better for the trimer than for the tetramer. However, they could make o...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.